Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Quinapril Hydrochloride Tablet
Status: Currently in Shortage
»Date first posted:
01/19/2023
»Therapeutic Categories: Cardiovascular
Aurobindo Pharma USA (Reverified 07/02/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Discontinued | Discontinuation of the manufacture of the drug | |
Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Discontinued | Discontinuation of the manufacture of the drug | |
Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Discontinued | Discontinuation of the manufacture of the drug | |
Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Discontinued | Discontinuation of the manufacture of the drug |
Chartwell Molecular Holdings LLC (Reverified 09/02/2024)
Company Contact Information:
845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Available | ||
Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Available | ||
Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Available | ||
Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Available |
Lupin Pharmaceuticals, Inc. (Reverified 08/19/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Unavailable | Requirements related to complying with good manufacturing practices | |
Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Unavailable | Requirements related to complying with good manufacturing practices | |
Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Unavailable | Requirements related to complying with good manufacturing practices | |
Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Unavailable | Requirements related to complying with good manufacturing practices |
Pfizer Inc. (Reverified 08/26/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Accupril, Tablet, 40 mg (NDC 0071-0535-23) | Unavailable | Next Delivery and Estimated Recovery: TBD | Delay in shipping of the drug |
Accupril, Tablet, 10 mg (NDC 0071-0530-23) | Unavailable | Next Delivery and Estimated Recovery: TBD | Delay in shipping of the drug |
Accupril, Tablet, 20 mg (NDC 0071-0532-23) | Unavailable | Next Delivery and Estimated Recovery: TBD | Delay in shipping of the drug |
Accupril, Tablet, 5 mg (NDC 0071-0527-23) | Unavailable | Next Delivery and Estimated Recovery: TBD | Delay in shipping of the drug |
Solco Healthcare US, LLC (Reverified 09/03/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Tablet, 5 mg (NDC 43547-410-09) | Unavailable | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Shortage of an active ingredient |
Tablet, 10 mg (NDC 43547-411-09) | Unavailable | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Shortage of an active ingredient |
Tablet, 20 mg (NDC 43547-412-09) | Unavailable | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Shortage of an active ingredient |
Tablet, 40 mg (NDC 43547-413-09) | Unavailable | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Shortage of an active ingredient |